Post by
beechguy on Oct 30, 2014 10:44pm
Telesta Therapeutics...the cure?
I will start off by saying, I thought the "no second trial needed" FDA news, would have taken us into the .70 to .80 range. So take my opinion with a grain of salt. As far as people selling because of warrants; there may be some resistance at .30 and .40 and then .50 (would be a double from here). Orphan approval should clean out most of those, with the extra exposure. Who knows, maybe one of these days, we will trade like a company that is less than 5 months away from final BLA submission. Perhaps Telesta Therapeutics will be the cure??? :)
Comment by
sometoast on Oct 31, 2014 10:30am
If approved, what is the consensus on potential earnings for BNC?